Teva in Ireland
Chances are, someone you know is living a healthier life because of our medicines; after all we are the largest supplier of prescription medicines to Irish pharmacies.1
Teva is a global pharmaceutical company serving 200 million people every day.
At this moment:
- An Irish parent is trusting a Teva medicine to help a sick child get well.
- An Irish doctor is writing a prescription for a Teva medicine, to improve her patient’s outcome.
- An Irish pharmacist is reaching for a Teva product, secure in the knowledge that Teva medicines meet the highest standards for quality and safety.
Teva is committed to providing medicines that serve people around the world, both prescription medications as well as over-the-counter treatments. We offer high-quality generic and specialty medicines to patients across a wide range of therapeutic areas. And, we are continually expanding our range of products and services to better meet the needs of Irish patients and healthcare professionals.
Teva – A key partner to the Irish Health Service
Like all health systems globally, the Health Service Executive is under huge pressure from rising patient demand from an aging population, often managing multiple chronic conditions and rising costs. At Teva we’re working hard to help the HSE do more with less by driving sustainability and value through our range of generic medicines and innovative medicines.
We’re focused on improving how long-term conditions are managed, addressing cost-efficient prescribing and ensuring high quality joined-up care for the patient. We’re also looking at healthcare options that are fit for the future, like new technologies, innovative devices, and a fresh approach to services.
Teva employs around 800 people in Ireland and has three sites in the Republic of Ireland and one site in Northern Ireland.
Central Nervous System (CNS)
Teva is committed to delivering medicines to meet the needs of patients and families affected by disorders of the Central Nervous System (CNS).
A global leader in treatments for disorders of the central nervous system (CNS), we provide medicines to treat patients with neurological and neurodegenerative disorders, pain, and sleep disorders, in countries around the world.
Teva is also developing innovative solutions in headache and migraine, and socially responsible pain treatments.
For further information on our products please refer to:
For COPAXONE® (glatiramer acetate injection) prescribing information click the following link:
1 Teva Data on File (DOF 187)